TASMAN PHARMA
Live / Registered — Registered (as of 08 Oct 2024)
What this means for you
Registered since 08 Oct 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Oct 2030: the §8 declaration of use).
Record
- Serial number
- 90237013
- Registration number
- 7530788
- Mark type
- Word mark
- Filed
- 06 Oct 2020
- Published for opposition
- 13 Apr 2021
- Registered
- 08 Oct 2024
- Next maintenance filing
- §8 declaration of use, due by 08 Oct 2030 (grace period to 08 Apr 2031)
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of psychiatric diseases and disorders
Owner
- Douglas Pharmaceuticals Limited, Lincoln, Auckland, NZ
- Douglas Pharmaceuticals Limited, Lincoln, Auckland, NZ
- Douglas Pharmaceuticals Limited, Lincoln, Auckland, NZ
Prosecution history
- 08 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 27 May 2024 — USE AMENDMENT FILED
- 27 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 15 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Dec 2023 — SOU EXTENSION 5 GRANTED
- 04 Dec 2023 — SOU EXTENSION 5 FILED
- 13 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jun 2023 — SOU EXTENSION 4 GRANTED
- 06 Jun 2023 — SOU EXTENSION 4 FILED